Powerful Medical Receives €40 Million IPCEI Grant — read the full story

Powerful Medical
8. October 2020

Video: Panel discussion on healthcare digitalization at Forbes Technology 2020

Martin Herman, our co-founder and CEO at Powerful Medical and Martin Smatana (Chief Business Officer of Medannot) have participated in the Forbes Technology 2020 panel discussion on Healthcare Digitalization, where they discussed data, AI, and the products we are bringing to market. They explain how Powerful Medical aids doctors in the diagnosis and treatment of cardiovascular diseases using an AI-powered clinical assistant and how its subsidiary Medannot automates diagnostics and annotation in 3D radiology imaging.

Powerful Medical

Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
Powerful Medical leads one of the most important shifts in modern medicine by augmenting human-made clinical decisions with artificial intelligence. Our primary focus is on cardiovascular diseases, the world’s leading cause of death.
About PMcardio:

PMcardio is a CE-certified AI that reads ECGs and offers a complex assessment of 49 cardiac conditions. Clinically validated in 15+ studies and trusted by over 100,000 clinicians, it delivers rapid, expert‑level interpretations, empowering emergency physicians, GPs, nurses, paramedics, and cardiologists to act with confidence at the point of care. Available for Individuals and Organizations.

About Powerful Medical:

Established in 2017, Powerful Medical has embarked on a mission to revolutionize the diagnosis and treatment of cardiovascular diseases. We are a medical company backed by 28 world-class cardiologists and led by our expert Scientific Board with decades of experience in daily patient care, clinical research, and medical devices. The results of our research are implemented, developed, certified, and brought to market by our 50+ strong interdisciplinary team of physicians, data scientists, AI experts, software engineers, regulatory specialists, and commercial teams.

Share this article

Don't miss these

Independent RCT and Late-Breaking Science: PMcardio to Take Center Stage at TCT 2025

We’re proud to share that PMcardio and the Queen of Hearts™ (STEMI AI ECG model) will be prominently featured at Transcatheter Cardiovascular Therapeutics (TCT) 2025, the largest interventional cardiology conference in the U.S., taking place October 25–27, 2025 in San Francisco, California.
Smartphone displaying RCEM Learning podcast episode “September 2025” featuring discussion of PMcardio’s Queen of Hearts™ AI outperforming doctors in ECG interpretation

Can AI Outperform Doctors in ECG Interpretation? (RCEM Learning Podcast, by Dr. Andy Neill and Dr. Dave McCreary)

In this RCEM Learning Podcast episode, Andy and Dave explore a study comparing doctors and PMcardio’s Queen of Hearts™ AI in ECG interpretation. Physicians achieved ~65% accuracy, while the AI reached ~89%, outperforming even cardiologists in spotting subtle occlusions — a shift with major implications for emergency medicine.

Join over 100,000 healthcare professionals who are already taking advantage of AI